Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2015171003) PROCESS FOR OBTAINING OPTICALLY ACTIVE PIRLINDOLE ENANTIOMERS AND SALTS THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2015/171003 International Application No.: PCT/PT2014/000027
Publication Date: 12.11.2015 International Filing Date: 09.05.2014
IPC:
C07B 57/00 (2006.01) ,C07D 487/06 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
B
GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
57
Separation of optically-active organic compounds
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
06
Peri-condensed systems
Applicants:
TECNIMEDE SOCIEDADE TECNICO-MEDICINAL S.A. [PT/PT]; Rua Tapada Grande, N.º 2 Abrunheira P-2710-089 Sintra, PT
Inventors:
PARDAL FILIPE, Augusto Eugénio; PT
EUFRÁSIO PEDROSO, Pedro Filipe; PT
ALMEIDA PECORELLI, Susana Marques; PT
CASIMIRO CAIXADO, Carlos Alberto Eufrásio; PT
LOPES, Ana Sofia da Conceição; PT
DAMIL, João Carlos Ramos; PT
E OLIVEIRA SANTOS, Pedro Paulo de Lacerda; PT
Agent:
FERREIRA PINTO, Francisca; Av. da República, 25 - 1º Lisboa P-1050-186 Lisboa, PT
Priority Data:
Title (EN) PROCESS FOR OBTAINING OPTICALLY ACTIVE PIRLINDOLE ENANTIOMERS AND SALTS THEREOF
(FR) PROCÉDÉ D'OBTENTION D'ÉNANTIOMÈRES DE PIRLINDOLE OPTIQUEMENT ACTIFS ET DE SELS DE CEUX-CI
Abstract:
(EN) The present invention provides a new process for obtaining optically active pirlindole enantiomers, in the form of a free base or in the form of pharmaceutically acceptable salts. The products obtained according to the present invention are enantiomerically pure and are useful in medicine.
(FR) La présente invention concerne un nouveau procédé d'obtention d'énantiomères de pirlindole optiquement actifs, sous forme d'une base libre ou sous forme de sels pharmaceutiquement acceptables. Les produits obtenus selon la présente invention sont énantiomériquement purs et sont utiles en médecine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)